Litcius/Paper detail

Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and Effectiveness

Jae Hee Cheon, Seong‐Su Nah, Hyoun Woo Kang, Yun Jeong Lim, Sang‐Hoon Lee, Sang Joon Lee, Sung Hyun Kim, Nahyun Jung, Jeong Eun Park, Yeo Jin Lee, Da Bee Jeon, Yeon Mi Lee, Jong Min Kim, Sung‐Hwan Park

2021Advances in Therapy19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInfliximabAnkylosing spondylitisBiosimilarRheumatoid arthritisInternal medicineIncidence (geometry)Psoriatic arthritisAdverse effectConfidence intervalInflammatory bowel diseaseRheumatologyAdalimumabObservational studySurgeryDiseasePhysicsOpticsBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies